- Home
- HEES vs CNTA Comparison
HEES vs CNTA Comparison
Compare HEES & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEES
- CNTA
- Stock Information
- Founded
- HEES 1961
- CNTA 2020
- Country
- HEES United States
- CNTA United Kingdom
- Employees
- HEES N/A
- CNTA N/A
- Industry
- HEES Misc Corporate Leasing Services
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- HEES Industrials
- CNTA Health Care
- Exchange
- HEES Nasdaq
- CNTA Nasdaq
- Market Cap
- HEES 2.1B
- CNTA 2.2B
- IPO Year
- HEES 2006
- CNTA 2021
- Fundamental
- Price
- HEES $56.68
- CNTA $18.19
- Analyst Decision
- HEES Buy
- CNTA Strong Buy
- Analyst Count
- HEES 6
- CNTA 7
- Target Price
- HEES $61.25
- CNTA $23.71
- AVG Volume (30 Days)
- HEES 295.6K
- CNTA 527.9K
- Earning Date
- HEES 10-29-2024
- CNTA 11-12-2024
- Dividend Yield
- HEES 1.95%
- CNTA N/A
- EPS Growth
- HEES N/A
- CNTA N/A
- EPS
- HEES 3.94
- CNTA N/A
- Revenue
- HEES $1,518,307,000.00
- CNTA $6,853,000.00
- Revenue This Year
- HEES $4.55
- CNTA N/A
- Revenue Next Year
- HEES $3.91
- CNTA N/A
- P/E Ratio
- HEES $14.36
- CNTA N/A
- Revenue Growth
- HEES 5.69
- CNTA N/A
- 52 Week Low
- HEES $40.92
- CNTA $5.58
- 52 Week High
- HEES $66.18
- CNTA $18.74
- Technical
- Relative Strength Index (RSI)
- HEES 54.79
- CNTA 64.61
- Support Level
- HEES $54.51
- CNTA $15.00
- Resistance Level
- HEES $60.66
- CNTA $18.74
- Average True Range (ATR)
- HEES 1.83
- CNTA 1.18
- MACD
- HEES -0.38
- CNTA 0.10
- Stochastic Oscillator
- HEES 61.60
- CNTA 85.29
About HEES H&E Equipment Services Inc.
H&E Equipment Services Inc is an integrated equipment services company. It is focused on heavy construction and industrial equipment. It rents, sells, and provides parts and services support for four core categories of equipment including hi-lift or aerial work platform equipment, cranes, earthmoving equipment, and industrial lift trucks. It engages in five principal business activities: equipment rentals; new equipment sales; sales of rental equipment; parts sales; and services. The majority of its revenue is derived from the equipment rentals segment.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.